We have identified you may not be viewing TRAVAX optimally because the browser you are using is unsupported - click here.
We have identified you may not be viewing TRAVAX optimally because the browser you are using is unsupported - click here.
In January 2012, GlaxoSmithKline (GSK) announced an interruption to the supply of Typherix® (Vi polysaccharide typhoid vaccine) and Hepatyrix® (hepatitis A and typhoid combined).
This was due to a delay in the availability of a new manufacturing facility and GSK is prioritising the production of essential childhood vaccines as required by WHO.
Currently:
Typherix® - is now out of stock until the second quarter at the earliest, 2014.
Hepatyrix® - is presently out of stock, however, a delayed supply is expected to be available to order towards the end of 2012. Stock is likely to be depleted early in 2013, until the second quarter 2014.
Havirx Monodose® and Havrix Junior Monodose® - are in supply although demand is high.
Enquiries to: GSK Customer Contact Team, Tel: 0808 100 9997
Ongoing Vaccine Supplies
Typhim Vi® (Vi polysaccharide typhoid vaccine) - Sanofi Pasteur MSD is experiencing a supply problem with the typhoid vaccine, Typhim Vi®. As such, they are unable to distribute further supplies at this time.
Avaxim® (hepatitis A vaccine) ViATIM® (hepatitis A/typhoid vaccine) - Sanofi Pasteur MSD, there are supply constraints on these products.
Currently there are no constraints to supply of Sanofi Pasteur MSD hepatitis A vaccine product: Vaqta Paediatric®.
Enquiries to: Sanofi Pasteur MSD Customer Operations team, Tel: 0800 085 5511.
Vivotif® (oral typhoid vaccine) - Crucell (UK) Ltd report no supply constraints for typhoid vaccine and Epaxal® (hepatitis A vaccine).
Enquiries to: Crucell (UK) Ltd, Customer services Tel:0844 800 3907
